Award
University of North Carolina at Chapel Hill RFA-AI-24-076
Ultra-long-acting in-situ forming implant (ISFI) as a subcutaneous injection for prevention of HIV and unplanned pregnancy
Recipient
University of North Carolina at Chapel Hill
Award Amount
$1,106,984.00
Ceiling
$1,106,984.00
Awarded
April 17, 2026
Identifier
RFA-AI-24-076
Award for developing a biodegradable implant to prevent HIV and unplanned pregnancy, supporting FDA processes and clinical translation.
Description
The project focuses on developing a biodegradable in-situ forming implant (ISFI) for HIV and pregnancy prevention. The project aims to support a pre-IND application, FDA meetings, and clinical translation. The project involves safety and pharmacokinetics evaluation in relevant animal models.